Login to Your Account



Genentech’s VEGF Drug Fails To Meet Phase II Endpoints


Friday, February 19, 1999
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription